Cannabis Bioscience International Holdings, Inc. (CBIH) Income from Continuing Operations (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Income from Continuing Operations across 5 years of filings, most recently posting -$104035.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations rose 31.42% year-over-year to -$104035.0; the TTM figure through Feb 2026 stood at -$547573.0 (down 22.39% YoY), while the FY2025 annual figure was -$557627.0, up 12.92% from the prior year.
• Income from Continuing Operations came in at -$104035.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from -$113737.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of -$70827.0 in Q4 2024 to a low of -$324655.0 in Q1 2023.
• Average Income from Continuing Operations over 5 years is -$166502.9, with a median of -$138321.5 recorded in 2024.
• Year-over-year, Income from Continuing Operations surged 54.75% in 2024 and plunged 90.22% in 2025.
• Over 5 years, Income from Continuing Operations stood at -$219886.0 in 2022, then soared by 43.41% to -$124428.0 in 2023, then surged by 43.08% to -$70827.0 in 2024, then plunged by 60.58% to -$113737.0 in 2025, then grew by 8.53% to -$104035.0 in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were -$104035.0 in Q1 2026, -$113737.0 in Q4 2025, and -$92152.0 in Q3 2025.